CD22 and systemic lupus erythematosus: While no associations with this polymorphism and SLE or RA disease susceptibility were found, the amino acid change within the CD22 cytoplasmic tail nonetheless might interfere its binding to PI3K, Lyn or SHP-1 and thus, affect CD22 downstream signaling.